
20/08/2025
Faculty Spotlight - Manalo Life Sciences / Vanderbilt University
GREGORY GERDEMAN, PH.D. www.patientsoutoftime.com Recognize major endocannabinoids and their molecular targets of action; discuss how the retrograde mechanism of endocannabinoid signaling allows neurons to tune their inputs by adjusting synaptic strength; and refer to the ECS to explain multiple therapeutic uses of cannabis.
Celebrating the 30th Anniversary of Patients Out of Time
The Sixteenth National Clinical Conference on Cannabis Therapeutics, Cannabis: From Prohibition to Recognition
September 14th-16th, 2025
Dr. Greg Gerdeman is a neuroscientist, cannabinoid researcher and entrepreneur with expertise in the physiological actions of cannabis and the endocannabinoid system (ECS), as well as many facets of cannabis cultivation, extraction and medicinal use.
His studies of cannabinoid physiology helped to pioneer views of the ECS as a cellular mechanism of homeostasis, and are widely cited in scientific literature. These findings include the discovery that endocannabinoids act as so-called retrograde messengers that regulate synaptic plasticity in the brain, which has become foundational to understanding ECS biology and the effects of cannabis. His collaborative research also showed that the runner’s high is mediated in large part by endocannabinoids, strongly implicating the ECS as a contributor to the therapeutic mechanisms of physical exercise. He has directed scientific operations for legal medical cannabis companies in multiple states, and he speaks on a wide array of subjects related to the science of the human-cannabis relationship.
drgerdeman.com